For the Inventor, By the Inventor

Enter assignee name

Bioprojet

USPTO Granted Patents = 24

CIPO Patents = 6

EPO Patents = 17

Forward Citations = 53

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Jeanne-Marie Lecomte (22 out of 55 patents)

Jean-Charles Schwartz (22 out of 62 patents)

Xavier Ligneau (14 out of 19 patents)

4. Marc Capet (12 out of 41 patents)

5. Philippe Robert (12 out of 13 patents)

6. Nicolas Levoin (10 out of 11 patents)

7. Isabelle Berrebi-Bertrand (9 out of 10 patents)

8. Thierry Calmels (7 out of 8 patents)

9. Olivier Labeeuw (6 out of 8 patents)

10. Stéphane Krief (5 out of 6 patents)

11. Xavier Billot (5 out of 6 patents)

12. Denis Danvy (5 out of 21 patents)

13. David Perrin (3 out of 7 patents)

14. Rajamannar Thennati (2 out of 43 patents)

15. Laurent Landais (2 out of 2 patents)

24 patents: Sort by Forward Citations

1. 12134608 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2024-11-05),

2. 12059416 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2024-08-13),

3. 11306069 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2022-04-19),

4. 11229632 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2022-01-25),

5. 11078183 - Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same (2021-08-03),

6. 10952987 - Combination of adrenalin with an antidepressant for use in the treatment of shocks (2021-03-23),

7. 9439853 - Form of administration of enkephalinase inhibitor (2016-09-13),

8. 9266867 - Piperidinyl monocarboxylic acids as S1P1 receptor agonists (2016-02-23),

9. 9255101 - 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands (2016-02-09),

10. 9242959 - (Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications (2016-01-26),

11. 9029357 - Benzazole derivatives as histamine H4 receptor ligands (2015-05-12),

12. 8809539 - Dicarboxylic acid derivatives as S1P1 receptor agonists (2014-08-19),

13. 8802678 - [object Object] (2014-08-12),

14. 8486947 - [object Object] (2013-07-16),

15. 8354430 - Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine (2013-01-15),

BIOPROJET is a pharmaceutical company specializing in the development and commercialization of innovative therapeutic solutions. With a focus on natural substances, BIOPROJET aims to improve patients' quality of life through the discovery of effective and safe treatments. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#191 in Paris

#851 in France

#25,865 in the World

Bioprojet

Forward Citations = 53

49 inventors:

Jeanne-Marie Lecomte (22 out of 55 patents)

Jean-Charles Schwartz (22 out of 62 patents)

Xavier Ligneau (14 out of 19 patents)

4. Marc Capet (12 out of 41 patents)

5. Philippe Robert (12 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…